TradingView
RocketTickers
19. Okt. 2020 16:34

Mereo BioPharma Announces FDA Clearance to Proceed into a Phase  Long

NASDAQ:MREO60
Mereo BioPharma Group plcNASDAQ

Beschreibung

⋅
MREO: Mereo BioPharma Group plc
2020-10-19 07:00:10
Mereo BioPharma Announces FDA Clearance to Proceed into a Phase 1b/2 study for Etigilimab (Anti-TIGIT)
Beyond Technical Analysis
Kommentare
VincePrince
⋅
These pharmas are risky but profitable
Mehr